THEOPHYLLINE
NDC 69315-226, THEOPHYLLINE, tablet, extended release, from Leading Pharma, LLC.
- Product NDC
- 69315-226
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214950
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE300 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-226-01 | 69315022601 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69315-226-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ac490ebf-24e1-47c4-a932-ad4dcafe7aadNADAC price for package 69315022601
GET /v1/drugs/nadac/69315022601
Use it
Look up 69315-226 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.